StockNews.com began coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Get Free Report) in a research note issued on Tuesday. The firm set a “sell” rating on the stock.
Ayala Pharmaceuticals Price Performance
Shares of Ayala Pharmaceuticals stock opened at $0.03 on Tuesday. The stock has a market cap of $1.28 million, a PE ratio of 0.00 and a beta of 1.68. The business has a fifty day simple moving average of $0.03 and a 200-day simple moving average of $0.04. Ayala Pharmaceuticals has a 12 month low of $0.00 and a 12 month high of $0.78.
Ayala Pharmaceuticals Company Profile
Further Reading
- Five stocks we like better than Ayala Pharmaceuticals
- Should You Invest in Penny Stocks?
- Can TikTok Stock Picks Really Make You Rich?
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- The “Quality” Rotation: Back to Basics Investing
- Options Trading – Understanding Strike Price
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for Ayala Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ayala Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.